ImmuCell Corporation Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ImmuCell Corporation (ICCC) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 599.26 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 599.26K shares, a 16.42% decline year-over-year.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 1.08M shares, a 67.90% increase year-over-year.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 717.00K shares, a 16.02% increase year-over-year.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 641.00K shares, a 6.92% increase year-over-year.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 664.00K shares, a 7.36% increase from fiscal 2023.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 618.50K shares, a 2.23% increase from fiscal 2022.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 605.00K shares, a 36.57% increase from fiscal 2021.
- ImmuCell Corporation antidilutive securities excluded from computation of earnings per share, amount for fiscal 2021 was 443.00K shares, a 7.00% increase from fiscal 2020.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 599.26K shares 10-Q · filed 2026-08-13 | 414.94K shares 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | 1.08M shares 10-Q · filed 2026-05-14 | |||||
| 2025-06-30 | 717.00K shares 10-Q · filed 2026-08-13 | |||||
| 2025-03-31 | 641.00K shares 10-Q · filed 2026-05-14 | |||||
| 2024-12-31 | 664.00K shares 10-K · filed 2025-03-28 | |||||
| 2024-09-30 | 661.00K shares 10-Q · filed 2024-11-13 | 661.00K shares 10-Q · filed 2024-11-13 | ||||
| 2024-06-30 | 618.00K shares 10-Q · filed 2025-08-14 | 618.00K shares 10-Q · filed 2025-08-14 | ||||
| 2024-03-31 | 599.50K shares 10-Q · filed 2025-05-14 | |||||
| 2023-12-31 | 618.50K shares 10-K · filed 2025-03-28 | |||||
| 2023-09-30 | 616.50K shares 10-Q · filed 2024-11-13 | 616.50K shares 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | 624.00K shares 10-Q · filed 2024-08-13 | 624.00K shares 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | 626.00K shares 10-Q · filed 2024-05-14 | |||||
| 2022-12-31 | 605.00K shares 10-K · filed 2024-04-01 | |||||
| 2022-09-30 | 563.00K shares 10-Q · filed 2023-11-13 | 563.00K shares 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | 548.00K shares 10-Q · filed 2023-08-10 | 548.00K shares 10-Q · filed 2023-08-10 | 78.00K shares 10-Q · filed 2022-08-11 | |||
| 2022-03-31 | 71.00K shares 10-Q/A · filed 2022-11-21 | |||||
| 2021-12-31 | 443.00K shares 10-K · filed 2022-03-30 | |||||
| 2021-09-30 | 0.00 shares 10-Q · filed 2022-11-21 | 452.00K shares 10-Q · filed 2022-11-21 | ||||
| 2021-06-30 | 62.00K shares 10-Q/A · filed 2022-11-21 | 442.00K shares 10-Q/A · filed 2022-11-21 | ||||
| 2021-03-31 | 409.00K shares 10-Q/A · filed 2022-11-21 | |||||
| 2020-12-31 | 414.00K shares 10-K · filed 2022-03-30 | |||||
| 2020-09-30 | 420.50K shares 10-Q · filed 2021-11-15 | 420.50K shares 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | 420.50K shares 10-Q · filed 2021-08-12 | |||||
| 2020-03-31 | 406.50K shares 10-Q · filed 2021-05-13 | |||||
| 2019-12-31 | 388.50K shares 10-K · filed 2021-03-30 | |||||
| 2019-09-30 | 370.00K shares 10-Q · filed 2019-11-12 | 370.00K shares 10-Q · filed 2020-11-12 | ||||
| 2019-06-30 | 379.00K shares 10-Q · filed 2019-08-12 | 379.00K shares 10-Q · filed 2020-08-12 | ||||
| 2019-03-31 | 87.00K shares 10-Q · filed 2020-05-13 | |||||
| 2018-12-31 | 394.00K shares 10-K · filed 2020-03-27 | |||||
| 2018-09-30 | 489.00K shares 10-Q · filed 2019-11-12 | 489.00K shares 10-Q · filed 2019-11-12 | ||||
| 2018-06-30 | 480.00K shares 10-Q · filed 2019-08-12 | 480.00K shares 10-Q · filed 2019-08-12 | ||||
| 2018-03-31 | 477.00K shares 10-Q · filed 2019-05-13 | |||||
| 2017-12-31 | 360.00K shares 10-K · filed 2019-03-22 | |||||
| 2017-09-30 | 367.00K shares 10-Q · filed 2018-11-13 | 63.00K shares 10-Q · filed 2018-11-13 | ||||
| 2017-06-30 | 368.00K shares 10-Q · filed 2018-08-13 | 120.00K shares 10-Q · filed 2018-08-13 | ||||
| 2017-03-31 | 184.00K shares 10-Q · filed 2018-05-14 | |||||
| 2016-12-31 | 34.25K shares 10-K · filed 2018-03-29 | |||||
| 2016-09-30 | 20.00K shares 10-Q · filed 2017-11-13 | 22.00K shares 10-Q · filed 2017-11-13 | ||||
| 2016-06-30 | 270.00K shares 10-Q · filed 2017-08-14 | 31.50K shares 10-Q · filed 2017-08-14 | 49.00K shares 10-Q · filed 2016-08-11 | |||
| 2016-03-31 | 14.00K shares 10-Q · filed 2017-05-11 | |||||
| 2015-12-31 | 6.00K shares 10-K · filed 2017-03-30 | |||||
| 2015-09-30 | 0.00 shares 10-Q · filed 2016-11-10 | 3.00K shares 10-Q · filed 2016-11-10 | ||||
| 2015-06-30 | 5.00K shares 10-Q · filed 2016-08-11 | 7.00K shares 10-Q · filed 2016-08-11 | ||||
| 2015-03-31 | 4.00K shares 10-Q · filed 2016-05-11 | |||||
| 2014-12-31 | 253.00K shares 10-K · filed 2016-03-25 | |||||
| 2014-09-30 | 85.00K shares 10-Q · filed 2015-11-12 | 251.00K shares 10-Q · filed 2015-11-12 | ||||
| 2014-06-30 | 246.00K shares 10-Q · filed 2015-08-13 | 246.00K shares 10-Q · filed 2015-08-13 | ||||
| 2014-03-31 | 246.00K shares 10-Q · filed 2015-05-12 | |||||
| 2013-12-31 | 63.88K shares 10-K · filed 2016-03-25 | |||||
| 2012-12-31 | 39.75K shares 10-K · filed 2015-03-26 | 43.00K shares 10-K · filed 2013-03-28 | ||||
| 2011-12-31 | 236.00K shares 10-K · filed 2014-03-26 | |||||
| 2010-12-31 | 273.50K shares 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |